BPG is committed to discovery and dissemination of knowledge
Articles in Press
11/16/2026 10:06:32 AM | Browse: 4 | Download: 0
Publication Name World Journal of Gastrointestinal Pharmacology and Therapeutics
Manuscript ID 126919
DOI 10.4292/wjgpt.126919
Country United Arab Emirates
Category Gastroenterology & Hepatology
Manuscript Type Minireviews
Article Title Is tirzepatide the next molecule for metabolic dysfunction-associated steatotic liver disease: A narrative review
Manuscript Source Invited Manuscript
All Author List George Sarin Zacharia, Sai Harsha Yendluri, Lav Shah, Anu Jacob, Reyansh Patel, Priscilla Hallal Lajara, Elona Shehi and Harish Patel
Funding Agency and Grant Number
Corresponding Author Anu Jacob, MD, Department of Anaesthesiology, Ahalia Hospital, Mussafah, Mussafah 2419, Abū Dhabi, United Arab Emirates. anuajcbo@yahoo.co.in
Key Words Metabolic dysfunction; Steatohepatitis; Steatotic liver disease; Tirzepatide; Glucagon-like peptide-1
Core Tip Tirzepatide is emerging as a promising treatment for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis (MASH). By promoting weight loss and improving insulin resistance, lipid metabolism, and hepatic inflammation, it addresses several key drivers of disease progression. Clinical studies have shown meaningful reductions in liver fat and liver injury, along with encouraging rates of MASH resolution and fibrosis improvement. However, definitive drug positioning requires phase III evidence addressing durability, optimal patient selection, treatment duration, combination strategies, and long-term hepatic outcomes.
Citation Zacharia GS, Yendluri SH, Shah L, Jacob A, Patel R, Lajara PH, Shehi E, Patel H. Is tirzepatide the next molecule for metabolic dysfunction-associated steatotic liver disease: A narrative review. World J Gastrointest Pharmacol Ther 2026; In press
PDF 126919-in-press.pdf
Received
2026-08-17 10:44
Peer-Review Started
2026-08-17 10:45
First Decision by Editorial Office Director
Return for Revision
2026-09-18 04:06
Revised
2026-09-26 18:51
Publication Fee Transferred
Second Decision by Editor
2026-11-16 05:24
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-11-16 10:06
Articles in Press
2026-11-16 10:06
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 2150-5349 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com